Royal Bank Of Canada Lannett CO Inc Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.45 - $0.86 $99 - $189	-220 Reduced 70.97%	90 $0
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.63 $777 - $1,064	-1,690 Reduced 84.5%	310 $0
Q2 2022 Aug 15, 2022	BUY	$0.47 - $0.87 $929 - $1,719	1,977 Added 8595.65%	2,000 $1,000
Q1 2022 May 16, 2022	SELL	$0.75 - $1.77 $796 - $1,879	-1,062 Reduced 97.88%	23 $0
Q4 2021 Feb 14, 2022	BUY	$1.56 - $2.93 $1,471 - $2,762	943 Added 664.08%	1,085 $2,000
Q3 2021 Nov 15, 2021	SELL	$2.91 - $4.83 $58 - $96	-20 Reduced 12.35%	142 $0
Q2 2021 Aug 16, 2021	BUY	$4.17 - $5.74 $675 - $929	162 New	162 $1,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.